Revance Therapeutics Inc (RVNC) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Revance Therapeutics Inc   (NASDAQ: RVNC)


Revance Therapeutics Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Revance Therapeutics Inc's ROI in the third quarter of 2024?
Revance Therapeutics Inc recorded a cumulative net loss of $-2 million during 12 months ending in the third quarter of 2024, resulting in a negative return on investment (ROI) of -0.4%.

Within the Healthcare sector 188 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2024 from 723 to 2470.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM -17.37 % -21.36 % -14.08 % -16.55 % -9.47 %
Y / Y Net Income Change TTM - - -90.29 % - -
Investment (TTM) in Millions 382 401 439 389 450
Return On Investment (TTM) -0.4 % 8.62 % 1.41 % -0.07 % -0.34 %
RVNC's Overall Ranking # 2470 # 723 # 1687 # 2184 # 2565
Seq. Investment Change TTM -4.1 % -6.79 % -1.67 % -6 % -8.73 %
Seq. Net Income Change TTM - 470.67 % - - -
Net Income (TTM) in Millions -2 36 6 0 -2

RVNC Company Profile >> Back to RVNC Roi Comparisons >> See Annual RVNC Return On Investment



Return On Investment RVNC's Ranking
Within: No.
Industry # 53
Sector # 189
Overall # 2470

Return On Investment Statistics
High Average Low
7.33 %
-35.76 %
-113.83 %
(Jun 30 2024)   (Dec 31 2019)







Financial Statements
Revance Therapeutics Inc's III. Quarter Investments $ 382 Millions RVNC's Balance sheet
Revance Therapeutics Inc's III. Quarter Income $ -38 Millions Quarterly RVNC's Income Statement
RVNC's Income by Division See RVNC's Income by Division


RVNC Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 389 506 464 659 299
Y / Y Investment Growth -23.11 % 9.13 % -29.64 % 120.26 % 97.31 %
Net Income in Millions 0 -1 -563 3 -319
Y / Y Net Income Growth - - - - -
Annual Return On Investment -0.08 % -0.14 % -121.29 % 0.4 % -106.53 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RVNC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RVNC's Competitors
Subscribers only: Roi for Revance Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for RVNC's Customers

Other Ratios
RVNC's Roa RVNC's Inventory Turnover Ratio RVNC's Growth Rates RVNC's Dividend Statistics
RVNC's Profitability Ratios RVNC's Asset Turnover Ratio RVNC's Dividend Growth
RVNC's Roe RVNC's Valuation Ratios RVNC's Financial Strength Ratios RVNC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-26T07:00:27+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.